Boston Scientific launched its Coyote balloon catheter, a highly deliverable and ultra-low profile 0.014 inch balloon dilatation catheter designed to treat patients undergoing peripheral angioplasty procedures below the knee. The company has begun marketing the product in the USA, Europe and other international markets.
The Coyote balloon catheter helps physicians to better treat patients with challenging obstructive lesions in the lower extremities. It features an ultra-low lesion entry profile (0.017 inch), excellent crossing profile and a shaft optimised for outstanding deliverability. The balloon offers rapid deflation times and is available in lengths up to 220 mm on both Over-the-Wire (OTW) and Monorail platforms.
“The Coyote balloon catheter’s low profile and ability to navigate through challenging vasculature make it ideal for treating vessels in the lower extremities,” said J A Mustapha, director of Endovascular Intervention at Metro Health Hospital in Wyoming, USA. “Its performance gives me greater confidence in being able to effectively treat patients with difficult anatomy who suffer from peripheral artery disease.”
Coyote is the latest in a series of innovative balloon catheter products introduced by Boston Scientific. In June, the company launched its Mustang PTA balloon catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures.
